Sharps Technology (STSS) Gains from Investment Securities (2021 - 2025)
Sharps Technology's (STSS) quarterly Gains from Investment Securities came in at $60025.0 in Q4 2025, up 11739.25% year-on-year from N/an in Q4 2024, and down 96.64% quarter-over-quarter from $1.8 million in Q3 2025.
Sharps Technology (STSS) Gains from Investment Securities (2021 - 2025) Analysis & Trends
Sharps Technology has disclosed Gains from Investment Securities across 5 years of filings, most recently posting $60025.0 for Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $60025.0, up 11739.25% year-over-year; the trailing twelve-month figure through Dec 2025 was $60025.0 (up 11739.25% YoY), and the FY2025 annual result was $60025.0, up 11739.25% from the prior year.
- Gains from Investment Securities came in at $60025.0 for Q4 2025 at Sharps Technology, down from $1.8 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $3.8 million in Q2 2024 to a low of -$1.0 million in Q4 2021.
- The 5-year median for Gains from Investment Securities is $60025.0 (2025), against an average of $685901.9.
- Across the five-year window, Gains from Investment Securities tumbled 129.99% in 2023 and jumped 11739.25% in 2025, its largest moves.
- Sharps Technology's Gains from Investment Securities stood at -$1.0 million in 2021, then jumped by 63.48% to -$370005.0 in 2022, then surged by 100.1% to $365.0 in 2023, then surged by 38.9% to $507.0 in 2024, then surged by 11739.25% to $60025.0 in 2025.
- The last three Gains from Investment Securities figures came in at $60025.0 (Q4 2025), $1.8 million (Q3 2025), and $501.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Sharps Technology | - | - | 1.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 60,025.00 |
| Dec 31, 2025 | 60,025.00 |
| Sep 30, 2025 | 1.79 Mn |
| Sep 30, 2025 | 1.79 Mn |
| Jun 30, 2025 | 501.00 |
| Jun 30, 2025 | 501.00 |
| Dec 31, 2024 | 507.00 |
| Dec 31, 2024 | 507.00 |
| Sep 30, 2024 | 18,592.00 |
| Sep 30, 2024 | 18,592.00 |
| Jun 30, 2024 | 3.78 Mn |
| Jun 30, 2024 | 3.78 Mn |
| Mar 31, 2024 | 2.41 Mn |
| Mar 31, 2024 | 2.41 Mn |
| Dec 31, 2023 | 365.00 |
| Dec 31, 2023 | 365.00 |
| Sep 30, 2023 | -110,230.00 |
| Sep 30, 2023 | -110,230.00 |
| Jun 30, 2023 | 2.36 Mn |
| Jun 30, 2023 | 2.36 Mn |